Although Nrf2 acts to prevent cancer by defending against oxidative stress, gain-of-function mutations in genes that encode the Nrf2 signaling pathway are found in many cancers, causing cell survival, metabolic reprogramming and tumor growth [[9], [10], [11], [12], [13], [14], [15], [16], [17]]. This evidence concerns the gene NFE2L2 and cancer.